Skip to main content
Robert Regenhardt, MD, Neurology, Boston, MA

RobertRegenhardtMDPhD

Neurology • Boston, MA

Interventional Neurology, Vascular Neurology, Neurointerventional Surgery

Neurointerventionalist

Join to view full profile

Dr. Regenhardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Regenhardt's full profile

Already have an account?

  • Office

    55 Fruit Street
    Boston, MA 02114

Summary

  • Robert W Regenhardt, MD, PhD is a neurointerventionalist at Massachusetts General Hospital. He completed college and medical school through an early acceptance program at the University of Florida in his home state. As he developed further interests in research, he pursued combined MD-PhD training. His dissertation work involved exploring neuroprotective effects of angiotensin peptides in both ischemic stroke and intracerebral hemorrhage using preclinical models. He completed neurology residency and vascular neurology fellowship at Harvard Medical School’s Massachusetts General Hospital and Brigham and Women’s Hospital. He then completed neuroendovascular fellowship at Massachusetts General Hospital. His research interests span the spectrum of translation, from understanding white matter ischemia and repair after stroke to improving stroke care systems for patients in Boston and abroad.

    Google Scholar: http://scholar.google.com/citations?user=jZAExNcAAAAJ
    ResearchGate: http://www.researchgate.net/profile/Robert_Regenhardt/?ev=hdr_xprf
    Doximity: https://www.doximity.com/pub/robert-regenhardt-md/1
    Twitter: https://twitter.com/rwregen
    ORCiD: http://orcid.org/0000-0003-2958-3484
    Harvard Catalyst: https://connects.catalyst.harvard.edu/Profiles/display/Person/139545
    Mendeley: https://www.mendeley.com/profiles/robert-regenhardt/
    Academia: https://hms-harvard.academia.edu/RobertRegenhardt
    Publons: https://publons.com/researcher/3097142/robert-w-regenhardt/

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endovascular Surgical Neuroradiology, 2020 - 2022
  • Massachusetts General Hospital
    Massachusetts General HospitalPost-Doctoral Fellowship, 2019 - 2020
  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Vascular Neurology, 2018 - 2019
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2015 - 2018
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiInternship, Preliminary Year, 2014 - 2015
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2014, MD, PhD

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Vascular Neurology
  • American Society of Neuroimaging, Intersocietal Commission for Accreditation of Vascular Laboratories, Registered Physician in Neurovascular InterpretationNeurosonology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

Journal Articles

  • Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy–Related Inflammation  
    Robert W Regenhardt, Alvin S Das, Bart K Chwalisz, Tracey A Cho, JAMA Neurology

Authored Content

  • Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy–Related InflammationJune 2020

Press Mentions

  • Stroke Indicator Found on MRI Could Help with Treatment Strategies
    Stroke Indicator Found on MRI Could Help with Treatment StrategiesFebruary 15th, 2023
  • Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive Stroke
    Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive StrokeFebruary 15th, 2023
  • Direct to Angio‐Suite Large Vessel Occlusion Stroke Transfers Achieve Faster Arrival‐to‐Puncture Times and Improved Outcomes
    Direct to Angio‐Suite Large Vessel Occlusion Stroke Transfers Achieve Faster Arrival‐to‐Puncture Times and Improved OutcomesNovember 1st, 2022
  • Join now to see all

Grant Support

  • White matter injury and repair after strokeNational Institutes of Health R25 Research Program2017–Present
  • Infarct growth despite thrombectomy for large vessel occlusion strokeSociety of Vascular and Interventional Neurology Pilot Research Grant2022–2023
  • Hemorrhagic transformation after endovascular thrombectomyHeitman Young Investigator Career Development Award2022–2023
  • Stroke mortality and disability in urban TanzaniaGlobal and Humanitarian Health Grant, Center of Expertise Harvard Medical School2016–2018
  • Stroke mortality and disability in urban TanzaniaGlobal Health Award Program2016–2018
  • Clinical biomarkers in acute strokeClinical and Translational Science Institute Pilot Study Grant2011–2014
  • Cerebroprotective actions of the ACE2/Ang-(1-7)/Mas axis during ischemic and hemorrhagic stroke in preclinical modelsMedical Guild Research Incentive Award2009–2014
  • Cerebroprotective actions of the ACE2/Ang-(1-7)/Mas axis during ischemic and hemorrhagic stroke in preclinical modelsNational Institutes of Health T32 Multidisciplinary Training Program in Hypertension2009–2014
  • Knockout of TRIP-Br2 and the development of metabolic syndrome in mice maintained on a high fat dietNational Institutes of Health T35 Medical Science Research Program2008–2009
  • Expression of cell adhesion molecules and cytokines/chemokines in murine colonic mucosa during zinc deficiencyUniversity Scholars Research Program2005–2007

Professional Memberships

External Links

  • LinkedInhttps://www.linkedin.com/pub/robert-w-regenhardt/37/967/139
  • ResearchGatehttp://www.researchgate.net/profile/Robert_Regenhardt?ev=hdr_xprf
  • Google Scholarhttp://scholar.google.com/citations?user=jZAExNcAAAAJ

Dr. Robert Regenhardt, Dr. Robert Regenhardt, MD, Dr. R Regenhardt